Myocardial injury due to G-protein coupled receptor-autoimmunity

Japanese Heart Journal

Volumn 39, Issue 3, 1998, Pages 261-274

  Matsui, Shinobu ^a   Fu, Michael L X ^b  

^a KANAZAWA MEDICAL UNIVERSITY   (Japan)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Autoantibody; Dilated cardiomyopathy; Experimental cardiomyopathy; G protein coupled receptor; Myocarditis; Synthetic peptide

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN; BETA 1 ADRENERGIC RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; MUSCARINIC M2 RECEPTOR;

ARTICLE; AUTOIMMUNITY; BINDING SITE; HEART DILATATION; HEART MUSCLE INJURY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RABBIT;

EID: 0031864518     PISSN: 00214868     EISSN: None     Source Type: Journal    
DOI: 10.1536/ihj.39.261     Document Type: Article

References (45)

1. Narula J, Haider N, Virmani R, et al. Apoptosis in myocytes in end-stage heart failure. N Engl J Med 1996; 355: 1182-9.
2. Rose NR, Herskowitz A, Neumann D, Neu N. Autoimmune myocarditis: a paradigm of post-infection autoimmune disease. Immunol Today 1988; 9: 117-20.
3. Klein R, Maisch B, Kochsiek K, Beg PA. Demonstration of organ specific antibodies against heart mitochondria (anti-M7) in sera from patients with some forms of heart diseases. Clin Exp Immunol 1984; 58: 283-92.
4. Schultheiss HP, Bolte HD. Immunological analysis of auto-antibodies against the adenine nucleotide translocator in dilated cardiomyopathy. J Mol Cell Cardiol 1985; 17: 603-17.
5. Wolff PG, Kühl U, Schultheiss HP. Laminin distribution and autoantibodies to laminin in dilated cardiomyopathy and myocarditis. Am Heart J 1989; 117: 1303-9.
6. Lauer B, Padberg K, Schultheiss HP, Strauer BE. Autoantibodies against human ventricular myosin in sera of patients with acute and chronic myocarditis. J Am Coll Cardiol 1994; 23: 146-53.
7. Neumann DA, Burek CL, Baughman KL, Rose NR, Herskowitz A. Circulating heart-reactive antibodies in patients with myocarditis or cardiomyopathy. J Am Coll Cardiol 1990; 16: 839-46.
8. Caforio ALP, Bonifacio E, Stewart JT, et al. Novel organ-specific circulating autoantibodies in dilated cardiomyopathy. J Am Coll Cardiol 1990; 15: 1527-34.
9. Latif N, Baker C, Dunn MJ, Rose ML, Brady P, Yacoub MH. Frequency and specificity of anti-heart antibodies in patients with dilated cardiomyopathy detected using SDS-PAGE and Western blotting. J Am Coll Cardiol 1993; 22: 1378-84.
10. Portig I, Pankuweit S, Maish B. Antibodies against stress proteins in sera of patients with dilated cardiomyopathy. J Mol Cell Cardiol 1997; 29: 2245-51.
11. Limas CJ, Goldenberg IF, Limas C Autoantibodies against β-adrenoceptors in human idiopathic dilated cardiomyopathy. Circ Res 1989; 64: 97-103.
12. 1-adrenergic receptor in patients with idiopathic dilated cardiomyopathy. J Clin Invest 1990; 86: 1658-63.
13. Rosenbaum MB, Chiale PA, Schejtman D, Levin M, Elizari MV. Antibodies to beta-adrenergic receptors disclosing agonist-like properties in idiopathic dilated cardiomyopathy and Chagas' disease. J Cardiovasc Electrophysiol 1994; 5: 367-75.
14. Fu LX, Magnusson Y, Bergh CH, et al. Localization of a functional autoimmune epitope on the muscarinic acetylcholine receptor-2 in patients with idiopathic dilated cardiomyopathy. J Clin Invest 1993; 91: 1964-8.
15. Goin JC, Leiros CP, Borda E, Borda LS. Interaction of human chagasic IgG with the second extracellular loop of the human heart muscarinic acetylcholine receptor: functional and pathological implications. FASEB J 1997; 10: 77-83
16. Fu LMX, Hoebeke J, Matsui S, et al. Autoantibodies against cardiac G-protein-coupled receptors define different populations with cardiomyopathy but not with hypertension. Clin Immunol Immunopathol 1994; 72: 15-20
17. Barry WH. Mechanisms of immune-mediated myocyte injury. Circulation 1994; 89: 2421-32.
18. Samuelson J. Disorders of the immune system. In: Kumar V, Cotram RS, Robbins SL, editors. Basic Pathology. 6th edition. Philadelphia: Sanders, 1997: 81-131.
19. Fowles RE, Bieber CP, Stinson EB. Defective in vitro suppressor cell function in idiopathic congestive cardiomyopathy. Circulation 1979; 59: 483-91.
20. Eckstein R, Mempel W, Bolte HD. Reduced suppressor cell activity in congestive cardiomyopathy and in myocarditis. Circulation 1982; 65: 1224-9.
21. Anderson JL, Carlquist JF, Hammond EH. Deficient natural killer cell activity in patients with idiopathic dilated cardiomyopathy. Lancet 1982; ii: 1124-7.
22. Sanderson JE, Koech D, Iha D, Ojiambo H. T-lymphocyte subsets in idiopathic dilated cardiomyopathy. Am J Cardiol 1985; 55: 755-8.
23. Rönnblom LE, Forsberg H, Evrin PE. Increased level of HLA-DR-expressing T lymphocytes in peripheral blood from patients with idiopathic dilated cardiomyopathy. Cardiology 1991; 78: 161-7.
24. Caforio ALP, Stewart JT, Bonifacio E, et al. Inappropriate major histocompatibility complex expression on cardiac tissue in dilated cardiomyopathy. Relative for autoimmunity? J Autoimmun 1990; 3: 187-200.
25. Herskowitz A, Ahmed-Ansari A, Neumann DA, et al. Induction of major histocompatibility complex antigen within the myocardium of patients with active myocarditis: a nonhistological marker of myocarditis. J Am Coll Cardiol 1990; 15: 624-34.
26. Koike S. Immunological disorders in patients with dilated cardiomyopathy. Jpn Heart J 1989; 30: 799-807.
27. Limas CJ, Goldenberg IF, Limas C. Soluble interleukin-2 receptor levels in patients with dilated cardiomyopathy. Circulation 1995; 91: 631-43.
28. Seko Y, Yamazaki T, Shinkai Y, et al. Cellular and molecular bases for the immunopathology of the myocardial damage involved in acute viral myocarditis with special reference to dilated cardiomyopathy. Jpn Circ J 1992; 56: 1062-72.
29. Toyozaki T, Saito T, Takano H, et al. Expression of intercellular adhesion molecule-1 on cardiac myocytes for myocarditis before and during immuno-suppressive therapy. Am J Cardiol 1993; 72: 441-4.
30. β genes in infiltrating cells in the hearts of patients with acute myocarditis and dilated cardiomyopathy. J Clin Invest 1995; 96: 1035-41.
31. Badorff C, Noutsias M, Kuhl U, Schultheiss HP. Cell-mediated cytotoxity in patients with dilated cardiomyopathy: correlation with interstitial fibrosis and foci of activated T lymphocytes. J Am Coll Cardiol 1997; 29: 429-34.
32. Yeh ETH. Autoimmunity and the pathogenesis of myocarditis. Circulation 1994; 89: 1318-9.
33. 1-adrenergic receptors in patients with malignant hypertension Lancet 1994; 344: 1660-3.
34. Matsui S, Fu LMX, Shimizu M, et al. Dilated cardiomyopathy defines serum autoantibodies against G-protein-coupled cardiovascular receptors. Autoimmunity 1995; 21: 85-8.
35. 1-adrenoceptor with positive chronotropic effect. Circulation 1994; 89: 2760-7.
36. 1-adrenoceptor autoantibodies with chronotropic activity from the serum of patients with dilated cardiomyopathy: mapping of epitopes in the first and second extracellular loops. J Mol Cell Cardiol 1995; 27: 397-406.
37. Fu MLX, Schulze W, Wallukat G, Hjalmarson Å, Hoebeke J. Functional epitope analysis of the second extracellular loop of the human heart muscarinic acetylcholine receptor. J Mol Cell Cardiol 1995; 27: 427-36.
38. Limas CJ, Limas C. Immune-mediated modulation of β-adrenoceptor function in human dilated cardiomyopathy. Clin Immunol Immunopathol 1993; 68: 204-7.
39. Caforio ALP, Keeling PJ, Zachara E, et al. Evidence from family studies for autoimmunity in dilated cardiomyopathy. Lancet 1994; 344: 773-7.
40. Dörffel WV, Felix SB, Wallukat G, et al. Short-term hemodynamic effects of immunoabsorption in dilated cardiomyopathy. Circulation 1997; 95: 1994-7.
41. 1-adrenergic receptor in patients with idiopathic dilated cardiomyopathy. J Autoimmun. 1991; 4: 893-905.
42. Beachey EH, Seyer JM, Dale JB, Simpson WA, Kang AH. Type-specific protective immunity evoked by synthetic peptide of streptococcus pyogenes M protein. Nature 1981; 292: 457-9.
43. Lerner RA, Green N, Alexander H, Liu F-T, Sutcliffe JG, Shinnick TM. Chemically synthesized peptides predicted from the nucleotide sequence of the hepatitis B virus genome elicit antibodies reactive with the native envelope protein of Dane particles. Proc Nad Acad Sci USA 1981; 78: 3404-7.
44. Schulze W, Fu MLX. Immunohistochemical localization of muscarinic receptors as an autoantigen in heart tissue. Int J Cardiol 1996; 54: 177-82.
45. Matsui S, Fu LXM, Katsuda S, et al. Peptides derived from cardiovascular G-protein-coupled receptors induce morphological cardiomyopathic changes in immunized rabbits. J Mol Cell Cardiol 1997; 29: 641-55.